Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Pds Biotechnology Corp (PDSB)

1.99   -0.15 (-7.01%) 10-31 15:44
Open: 2.06 Pre. Close: 2.14
High: 2.14 Low: 1.94
Volume: 597,779 Market Cap: 44M
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. Its therapies are developed for the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Versamune is its synthetic lipid-based immunotherapy platform. Its lead product candidate, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. Its pipeline also includes PDS0102, PDS0103 and PDS0104. Its pipeline of Versamune-based products are all administered by subcutaneous injection .DS0102 is being developed for the treatment of prostate and breast cancers. PDS0103 is based on novel agonist antigens of the mucin-1 (MUC-1) oncogenic C-terminal region. PDS0104 is being developed for the treatment of melanoma.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.146 - 2.158 2.158 - 2.168
Low: 1.906 - 1.921 1.921 - 1.934
Close: 1.967 - 1.99 1.99 - 2.009

Technical analysis

as of: 2020-10-30 4:35:57 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.63     One year: 2.91
Support: Support1: 1.87    Support2: 1.56
Resistance: Resistance1: 2.25    Resistance2: 2.49
Pivot: 2.20
Moving Average: MA(5): 2.05     MA(20): 2.24
MA(100): 2.50     MA(250): 2.01
MACD: MACD(12,26): -0.11     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 23.12     %D(3): 23.29
RSI: RSI(14): 40.49
52-week: High: 4.98  Low: 0.62  Change(%): -35.2
Average Vol(K): 3-Month: 65351  10-Days: 37462

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
PDSB has closed above bottom band by 14.7%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to PDSB's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 28 Sep 2020
PDS Biotechnology to Present Results from its Phase 1 Trial of PDS0101 and the Phase 2 Clinical Strategy in Patients with Advanced HPV-Associated Malignancies - GlobeNewswire

Mon, 31 Aug 2020
PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series - GlobeNewswire

Thu, 13 Aug 2020
PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares - GlobeNewswire

Tue, 11 Aug 2020
PDS Biotechnology Corporation Announces Pricing of $16.5 Million Public Offering of Common Stock - GlobeNewswire

Mon, 10 Aug 2020
PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock - GlobeNewswire

Mon, 22 Jun 2020
PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 22
Shares Float (M) 12
% Held by Insiders 35.92
% Held by Institutions 5.03
Shares Short (K) 542
Shares Short P. Month (K) 697

Stock Financials

EPS -1.865
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.110
Profit Margin
Operating Margin
Return on Assets (ttm) -40.4
Return on Equity (ttm) -89.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.665
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -11

Stock Valuations

PE Ratio -1.07
PEG Ratio
Price to Book value 1.79
Price to Sales
Price to Cash Flow -2.59

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.